The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial

EuroIntervention 2016;12:e167-e174 published online e-edition June 2016. DOI: 10.4244/EIJV12I2A30

1. Department of Internal Medicine II, University of Ulm, Ulm, Germany; 2. Department of Cardiology, Saiseikai Yokohama City Eastern Hospital, Kanagawa, Japan; 3. Department of Cardiology, Kurashiki Central Hospital, Okayama, Japan; 4. Cardiac Catheteriza

Aims: CENTURY II is a prospective, multicentre, randomised, single-blind trial comparing the bioresorbable polymer sirolimus-eluting Ultimaster® stent (BP-SE

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: a systematic review and meta-analysis